Alnylam Pharmaceuticals Inc
ALNY
historical activity
| Quarter | Shares | +/- Shares | Change % | Value($) | % of Total value | Avg Report Price($) |
|---|---|---|---|---|---|---|
| Q3 2024 | 4.9M | -1.1M | ↓18.99% | 1.3B | 1% | 275.03 |
| Q2 2024 | 6.0M | -590.9K | ↓8.92% | 1.5B | 1.14% | 243.00 |
| Q1 2024 | 6.6M | -343.5K | ↓4.93% | 989.9M | 0.76% | 149.45 |
| Q4 2023 | 7.0M | -1.2M | ↓14.65% | 1.3B | 1.05% | 191.41 |
| Q3 2023 | 8.2M | -229.1K | ↓2.73% | 1.4B | 1.31% | 177.10 |
| Q2 2023 | 8.4M | -246.9K | ↓2.86% | 1.6B | 1.35% | 189.94 |
| Q1 2023 | 8.6M | -768.7K | ↓8.17% | 1.7B | 1.56% | 200.32 |
| Q4 2022 | 9.4M | -106.9K | ↓1.12% | 2.2B | 2.32% | 237.65 |
| Q3 2022 | 9.5M | -453.7K | ↓4.55% | 1.9B | 1.96% | 200.16 |
| Q2 2022 | 10.0M | -171.3K | ↓1.69% | 1.5B | 1.49% | 145.85 |
| Q1 2022 | 10.1M | -477.0K | ↓4.49% | 1.7B | 1.16% | 163.29 |
| Q4 2021 | 10.6M | = | = | 1.8B | 0.98% | 169.58 |